{"id":113541,"date":"2026-02-01T11:11:23","date_gmt":"2026-02-01T17:11:23","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=113541"},"modified":"2026-02-11T16:49:43","modified_gmt":"2026-02-11T22:49:43","slug":"la-maladie-de-erdheim-chester-explications-symptomes-diagnostic-et-avancees-de-la-recherche","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/fr\/erdheim-chester-disease-explained-symptoms-diagnosis-research-advances\/","title":{"rendered":"Webinaire en fran\u00e7ais avec le Dr J\u00e9r\u00f4me Razanamahery : \u00ab ECD : d\u00e9cryptage des diagnostics et des traitements \u00bb"},"content":{"rendered":"<p>Dans ce webinaire sp\u00e9cial consacr\u00e9 au d\u00e9veloppement de la petite enfance (ECD), <strong>le Dr J\u00e9r\u00f4me Razanamahery,<\/strong> m\u00e9decin sp\u00e9cialiste en m\u00e9decine interne \u00e0 <strong>Centre hospitalier universitaire de Dijon<\/strong>, un <strong>Centre de prise en charge des cas orient\u00e9s par l'ECD<\/strong>, parle de <strong>Maladie d'Erdheim-Chester (ECD)<\/strong>. Il explique ce qu'est l'ECD, pourquoi elle peut \u00eatre difficile \u00e0 diagnostiquer et comment les nouveaux traitements cibl\u00e9s contribuent \u00e0 am\u00e9liorer les r\u00e9sultats cliniques des patients.<\/p>\n<p><strong>Ce webinaire est pr\u00e9sent\u00e9 en fran\u00e7ais<\/strong>.<\/p>\n<p>Cette vid\u00e9o contient un message de <strong>Le professeur Julien Haroche,<\/strong> un m\u00e9decin-chef \u00e0 l'h\u00f4pital <strong>Centre de prise en charge des cas r\u00e9f\u00e9r\u00e9s pour les troubles du d\u00e9veloppement pr\u00e9coce \u00e0 l'H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re de Paris, en France<\/strong>. Il dirige le Centre de r\u00e9f\u00e9rence fran\u00e7ais pour l'histiocytose.<\/p>\n<p>La vid\u00e9o pr\u00e9sente \u00e9galement le t\u00e9moignage \u00e9mouvant d'un patient qui <strong>M. Jacques Dutu,<\/strong> qui partage avec courage son parcours avec ECD, depuis ses sentiments de col\u00e8re et de d\u00e9sarroi jusqu\u2019\u00e0 l\u2019espoir et l\u2019autonomisation.<\/p>\n<p><strong>Vous apprendrez :<\/strong><\/p>\n<ul>\n<li>Qu'est-ce qui fait de l'ECD un cancer du sang inflammatoire rare et complexe ?<\/li>\n<li>Pourquoi le retard de d\u00e9veloppement de la petite enfance est difficile \u00e0 diagnostiquer \u00e0 un stade pr\u00e9coce, et quels sympt\u00f4mes surveiller<\/li>\n<li>Comment des mutations telles que <strong>BRAFV600E<\/strong> influencer les choix th\u00e9rapeutiques<\/li>\n<li>Comment les traitements cibl\u00e9s, tels que <strong>BRAF et MEK<\/strong> les inhibiteurs, aident les patients<\/li>\n<li>Pourquoi le soutien en mati\u00e8re de sant\u00e9 mentale et la qualit\u00e9 de vie sont importants<\/li>\n<li>Pourquoi le <strong>Alliance mondiale ECD<\/strong> existe et en quoi elle aide les patients et leurs familles \u00e0 travers le monde<\/li>\n<\/ul>\n<p>Cette vid\u00e9o s'inscrit dans le cadre de notre mission permanente visant \u00e0 sensibiliser le public, \u00e0 apporter un soutien et \u00e0 contribuer \u00e0 faire avancer la recherche au profit des personnes touch\u00e9es par <strong>Maladie d'Erdheim-Chester.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>In this special ECD webinar, Dr. Jerome Razanamahery, an internal medicine doctor at Dijon University Hospital, an ECD referral care center, talks about Erdheim-Chester Disease (ECD). He explains what ECD [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":113542,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"yes","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[351],"tags":[5676,5675,5678,387,5317,102,5674,5679,5677,116,4966,5673,4961,4958],"class_list":["post-113541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinar-recordings","tag-braf-inhibitors","tag-brafv600e-mutation","tag-dr-jerome-razanamahery","tag-ecdga","tag-erdheim-chester-disease","tag-histiocytosis","tag-inflammatory-myeloid-neoplasm","tag-julien-haroche","tag-mek-inhibitors","tag-patient-support","tag-rare-blood-cancer","tag-rare-disease-awareness","tag-rare-disease-research","tag-targeted-therapy"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts\/113541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/comments?post=113541"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts\/113541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media\/113542"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media?parent=113541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/categories?post=113541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/tags?post=113541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}